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Abstract Velo-cardio-facial syndrome (VCFS) is char-
acterized by a high prevalence of depression and anxiety
disorders in childhood and adolescence. These disorders are
a source of great impairment in everyday functioning, as
well as important risk factors for the emergence of later
psychotic disorders. Impairment in daily and social func-
tioning as well as loss of IQ throughout growth are also are
well-established correlates of the VCFS. This study aimed
to confirm the high prevalence of depression and anxiety
disorders. The second objective was to ascertain the cor-
relation between anxious and depressive symptoms and the
decline in adaptive and cognitive functioning. A total of 73
children and adolescents with VCFS (mean age 11.9 years)
underwent psychiatric evaluation. Subjects were further
divided into four age groups: ages 6–9, 9–12, 12–15 and
15–18 years. Assessments measuring intelligence, anxious
and depressive symptoms, and adaptation skills reported by
parents were submitted to a subsample of 62 children (mean
age 12.2 years); 62.2 % of the sample showed an anxiety
disorder, specific phobia being the most represented at all
ages. Lifetime depression concerned 27 % of the sample,
peaking at age 12–15 years. Anxious and depressive
symptoms and low IQ were significantly associated with
low adaptive functioning. Anxiety and depression are
common disorders in children and adolescents with VCFS
and have a great impact on adaptive functioning. Clinicians
should pay great attention to diagnosis and treatment.
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Abbreviation
DICA Diagnostic Interview for Children and
Adolescents
Introduction
Depression and anxiety disorders in children have recently
aroused great interest among researchers in the field of
velo-cardio-facial syndrome [1–5]. These pathologies are
highly prevalent, can have a dramatic impact on the daily
lives of patients and their families and can affect future
development. Also known as DiGeorge or Shprintzen
syndrome, VCFS is a genetic neurodevelopmental disorder
involving a microdeletion on the long arm of chromosome
22 at the q11.22 band. Clinical features include palatal
abnormalities, cardiac defects, unique facial characteristics,
hypernasal speech, hypotonia and thymus defects. At
present, the estimated prevalence of the syndrome ranges
from 1/6,000 to 1/2,000 [6]. However, VCFS’s great var-
iability in terms of clinical expression (up to 180 clinical
traits have been recognized and are not all displayed by
affected individuals [7]) reasonably implies that many
cases still go undiagnosed.
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In the past decades, a large number of published studies
on VCFS have reported an increased rate of psychiatric
disorders, including ADHD, anxiety disorders (such as
simple phobia and social phobia, general anxiety disorder,
obsessive–compulsive disorder), schizophrenia, major
depressive disorder, dysthymia and autism spectrum dis-
orders [8]. The prevalence of psychiatric disorders varies
among different studies, according to the mean age of the
sample, recruitment sources and cultural bias. A recent
study by Green and collaborators reported a psychopa-
thology prevalence of about 73 % among individuals with
velo-cardio-facial syndrome [5]. Moreover, most studies on
the VCFS show a high rate of ADHD and anxiety disorders
in children and adolescents [1, 9], whereas mood disorders
and schizophrenia tend to emerge later in adulthood [11–
14].
Research on psychotic disorders is overrepresented
among the studies on VCFS, which is partly related to the
severity of their clinical expression and by the degree of
impairment caused to the patients and their families. As a
consequence, the strong clinical association between
schizophrenia and VCFS has motivated concomitant
research in the field of genetic etiology, brain development
and the pathogenesis of psychotic disorders in VCFS
[11–13, 15].
The research on VCFS focusing on psychiatric disorders
appearing in early and middle childhood have underlined
the high prevalence of anxiety disorders at all ages, par-
ticularly concerning specific phobia. While appearing to
peak in adulthood, mood disorders are also a major concern
during childhood and adolescence. Clinical accounts often
reflect that depression and anxiety can be a challenging
issue for caregivers and a source of great impairment in
everyday functioning, social well-being and academic
achievement for patients. Moreover, parent-reported anx-
ious and depressive symptoms are important risk factors for
the emergence of psychotic disorders in adulthood [16].
During childhood and adolescence, the occurrence of
psychotic symptoms is associated with more severe parent-
reported anxious-depressive symptoms [17].
The first purpose of our study was to confirm the high
prevalence of anxiety and mood disorders among children
and adolescents affected by VCFS, and in particular to
assess the differences between childhood and adolescent
psychopathology. VCFS, like other genetic disorders, is
often associated with high impairment in daily routine and
family functioning and social performance [18]. The
adverse influence of anxious and depressive symptoms on
children’s social, academic and family functioning has also
been well established [19]. Therefore, the second objective
was to ascertain the effects of anxious and depressive
symptoms of children and adolescents affected by VCFS
on their level of impairment in adaptive, social and family
functioning, controlling for age, gender and intellectual
functioning. Since impairment in cognitive abilities and
evolving psychopathology throughout growth are well-
established correlates of the velo-cardio-facial syndrome, a
further concern was the predictive value of age and IQ on
the loss of daily functioning skills.
Methods
Participants
Seventy-four children and adolescents (36 males, 38
females) with VCFS between the ages of 6 and 18
(M = 11.9 ± 3.35) participated in this study. The presence
of the 22q11.2 microdeletion was confirmed by fluores-
cence in situ hybridization. Sixty-two children in the
sample (28 males, 34 females) aged 6–17 years (M =
12.2 ± 3.2) underwent clinical and cognitive assessment.
Participants were recruited through several European
VCFS patient associations (Switzerland, France, England
and Belgium). In order to avoid recruitment biases, sub-
jects referred by psychiatric or pediatric units were not
included in the sample. All patients were Caucasian,
French or English speaking and were tested in their native
language. In the entire sample, 64 % was receiving psy-
chotherapy or had received it in the past; 20 % of the
participants were being treated with psychotropic medica-
tions at the time of evaluation. The remaining part of the
sample was drug naı¨ve. Written informed consent was
received from all parents and/or subjects under protocols
approved by the Institutional Review Board of the Uni-
versity of Geneva School of Medicine.
Clinical evaluation
Participants’ parents were given a semi-structured com-
puterized interview called the DICA-IV [20]. The parental
responses to this computerized inventory were automati-
cally tabulated and scored by the DICA-P software gen-
erating specific DSM-IV diagnoses and a complete listing
by diagnostic criteria of all symptoms reported present or
absent by the parents. Diagnosis was then confirmed by a
clinical evaluation of the child. All the procedures were
performed by the same senior child and adolescent psy-
chiatrist (SE).
Cognitive evaluation
The children and adolescents’ general intellectual func-
tioning was assessed by well-trained master-level psy-
chologists using the Wechsler Intelligence Scale for
Children and the Wechsler Adult Intelligence Scale
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[21, 22]. Participants showed a mean borderline IQ (71.3 ±
11.2).
Adaptive behavior measures
The Vineland Adaptive Behavior Scales, Interview Edi-
tion, Survey Edition [23] was used to measure children and
adolescents’ personal and social skills. Well-trained psy-
chologists interviewed parents in their native language.
Results were organized within a three-domain structure.
The Communication domain reflects expressive and writ-
ten communication skills, as well as the ability to listen.
The Daily Living Skills domain assesses personal habits
and domestic task performance as well as behavior in the
community. The Socialization domain evaluates interper-
sonal relationships, play, leisure time activities and various
interaction skills.
Emotional assessment
The severity of depressive symptoms was assessed with the
Children’s Depression Inventory (CDI) [24], a self-report
questionnaire of 27 items adapted for children and ado-
lescents aged 7–17 yeara. Each item consists of three
choices, keyed 0/1/2, with higher scores indicating
increasing severity. This test quantifies a range of depres-
sive symptoms including disturbed mood, hedonic capac-
ity, vegetative functions, self-evaluation and interpersonal
evaluation. Anxious symptoms were assessed with the
Children’s Manifest Anxiety Scale-Revised (R-CMAS)
[25], a self-reported measure of 37 items that evaluates the
level and the nature of anxiety, from somatic complaints to
social correlates, in children and adolescents aged
6–19 years. The questionnaire is divided into four sub-
scales: Physiological Anxiety (10 items), Worry/Over-
sensitivity (11 items), Social Concerns/Concentration (7
items), and the Lie Scale (9 items). All patients completed
the questionnaires prior to their clinical evaluation.
Statistical analyses
We first performed descriptive statistics on the prevalence
of anxiety and mood disorders in a sample of 74 children
and adolescents with VCFS. We further divided our sample
into four age groups (6–9 years, 9–12 years, 12–15 years,
15–18 years) to examine the age distribution of these dis-
orders. We computed confidence intervals for prevalence
using the Minitab 16 Statistical Software (http:\\www.
minitab.com). We then performed Chi-square tests to
compare the prevalence between age groups.
Secondly, we compared the RCMAS and the CDI total
scores between age groups using MANOVAs and post hoc
Tukey HSD pairwise comparisons.
Finally, we performed stepwise linear regressions to
identify the best predictors of adaptive functioning in a
subsample of 62 individuals (mage = 12.17, SD = 3.21).
Adolescents aged 16 years or higher were not included in
the present analyses since the adult version of the RCMAS
(mtotal score = 56.29, SD = 10.394) and the CDI (mtotal score =
54.47, SD = 9.104) were used for these participants. The
Vineland total score was used as dependant variable. Age,
gender, full-scale IQ, anxiety total score and depression
total score were used as stepwise independent variables.
We created two separate models, one using the anxiety
total score and the other using the depression total score, in
order to avoid multicollinearity.
All the analyses excepting confidence interval calcula-
tions were performed using SPSS Statistical Software
version 19.
Results
Prevalence of anxiety disorders and depression
The rate of anxiety disorders and depression in the entire
sample is presented in Table 1. A current anxiety disorder
was found in 62.2 % of the sample (46 subjects). The most
common anxiety disorder is specific phobia (46 %) fol-
lowed by general anxiety disorder (14.9 %), social phobia
(10.8 %), obsessive–compulsive disorder (9.5 %) and
separation anxiety (8.1 %). Current or past depression was
present in 29 % of the subjects.
Though the four age groups showed different prevalence
rates for anxiety disorders and depression, Chi-square
comparisons revealed that they did not significantly differ,
as reported in Table 2. The youngest group of children
(aged 6–9 years) showed a high rate of specific phobia
(29.4 %) in comparison to the other disorders namely
separation anxiety, general anxiety disorder (GAD),
obsessive–compulsive disorder (OCD) and depression
which are all equally represented at 17.6 %. Only one
patient fulfilled the criteria for social phobia. In the group
of children aged 9–12 years, specific phobia was still
highly represented (45 %). Depression and GAD were
diagnosed in 20 % of the sample, while social phobia rose
to 15 %. Separation anxiety was diagnosed in only one
patient as was OCD. Only one patient was diagnosed with
separation anxiety and only one with OCD. The preado-
lescent group (12–15 years old) showed their highest per-
centage of psychiatric disorder for depression (42.1 %) and
specific phobia (52.6 %). Separation anxiety and OCD
appeared in 10.5 % of the sample while social phobia was
reduced to 5.3 %. Specific phobia was by far the most
represented disorder in the adolescent group (66.7 %),
followed by depression (27.8 %) and social phobia
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(16.7 %). The percentages of GAD and OCD dropped to
5.6 %. No adolescent currently had separation anxiety
disorder.
Concerning the specific phobia disorder, several chil-
dren reported more than one type of phobia. A large part of
the phobic subjects (25 participants) reported fear of the
dark. Among the other specific phobias, 17 were scared of
animals (e.g., dogs and insects), 12 of natural causes (e.g.,
thunderstorms and wind) and 5 feared heights and avoided
noise and different situations such as taking a plane or an
elevator. The fear of being left alone was experienced by
four participants.
Association with adaptive functioning
A first stepwise linear regression indicated that full-scale
IQ (b = 0.363, p \ 0.05), CDI total score (b = -0.320,
p \ 0.05) and age (b = -0.294, p \ 0.05) significantly
predicted adaptive functioning (see Table 3). The final
model with all the predictors explained 41.6 % of variance.
A second stepwise linear regression indicated that full-
scale IQ (b = 0.379, p \ 0.05), RCMAS total score
(b = -0.263, p \ 0.05) and age (b = -0.250, p \ 0.05)
significantly predicted adaptive functioning (see Table 3).
The final model with all the predictors explained 38.3 % of
variance. These results are consistent with our second
hypothesis.
Discussion
Anxiety disorders and depression are very common in
individuals with VCFS. In this study, 27 % of children and
adolescents suffered from major depression currently or in
the past. This rate is considerably higher than the 5 %
estimated prevalence in school age population without
VCFS [26]. Interestingly, the rate of depression in our
sample is higher than the results reported in some previous
studies in youth with VCFS [1, 3]. Sample sizes or dif-
ferences in age ranges could account for some of these
Table 1 Prevalence of
psychiatric disorder (Diagnostic
DSM-IV) in children with
VCFS and adolescents for total
sample and divided by age
groups
a Generalized anxiety disorder
b Obsessive compulsive
disorder
Total sample
N = 74 N (%)
6–9 years
N = 17
N (%)
9–12 years
N = 20
N (%)
12–15 years
N = 19
N (%)
15–18 years
N = 18
N (%)
Separation anxiety 6 (8) 3 (17.6) 1 (5) 2 (10.5) 0
GADa 11 (15) 3 (17.6) 4 (20) 3 (15.8) 1 (5.6)
Specific phobia 36 (49) 5 (29.4) 9 (45) 10 (52.6) 12 (66.7)
Social phobia 8 (11) 1 (5.9) 3 (15) 1 (5.3) 3 (16.7)
OCDb 7 (9) 3 (17.6) 1 (5) 2 (10.5) 1 (5.6)
Table 2 Prevalence of depression and anxiety in children and adolescents for total sample and divided by age groups and v2 differences between
age groups
Total sample
N = 74
N (%/Int-conf.)
6–9 years
N = 17
N (%/Int-conf.)
9–12 years
N = 20
N (%/Int-conf.)
12–15 years
N = 19
N (%/Int-conf.)
15–18 years
N = 18
N (%/Int-conf.)
v2 statistic
Depression 20 (27/17-39) 3 (17.6/4-43) 4 (20/6-44) 8 (42.1/20-66) 5 (27.8/10-53) 3.455, df = 3, p = 0.327
Anxiety 56 (76/64-85) 8 (47.1) 23-72 12 (60/36-81) 14 (73.3/49-91) 12 (66.7/41-87) 2.916, df = 3, p = 0.405
Table 3 Stepwise regression models to identify the best predictors of adaptive functioning (N = 62)
Dependent variable Model Coefficients
Significant independent variables DR2a DFa b SD b b t p
Vineland total score
QIT 0.246 19.538 0.350 0.102 0.363 3.414 0.001
CDI total 0.092 8.176 -0.379 0.120 -0.320 -3.148 0.003
Age 0.079 7.832 -0.990 0.354 -0.294 -2.799 0.007
Vineland total score
QIT 0.246 19.538 0.366 0.105 0.379 3.485 0.001
RCMAS total 0.081 7.109 -0.273 0.109 -0.263 -2.501 0.015
Age 0.056 5.296 -0.841 0.365 -0.250 -2.301 0.025
a DR2 and DF change in R2 and F coefficient from step1
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differences. The variability of the assessments (question-
naires vs. parents and child interviews vs. child alone) and
a possible diagnostic overlapping between anxiety and
depressive disorders are also likely to account for the
observed differences. However, other studies have found
similar results to ours [27].
We observed an increase in depressive episodes at the
beginning of adolescence (age 12–15), as previously
reported in a longitudinal study from Anthshel et al. [28].
Given the fact that in the general population depressive
disorders mainly appear in late adolescence and early
adulthood, this finding could be considered a specific fea-
ture of VCFS. Specific factors could play a role in this
particular trajectory.
Indeed, clinical observations show that by the age of
12–15 years, preadolescents with VCFS begin to struggle
with the psychosocial ramifications of their disorder.
Typically at this age, the quest for autonomy from parental
figures and the need to independently develop peer rela-
tionships amplify the contrast between ordinary and
affected individuals. Due to their lack of autonomy, low
communication skills and angry temperament, pre-adoles-
cents with VCFS are often unable to meet the social and
intellectual standards of their peers. Social isolation and
poor grades often result in low self-esteem and highly
increase susceptibility to depression.
In a similar way, the beginning of adulthood corresponds to
a difficult time emphasizing the syndrome’s consequences. At
the end of high school, individuals with VCFS often face
limited professional and relational opportunities due to their
physical and cognitive handicaps. This period of time corre-
sponds to a critical time for depression, as recently identified
by Green [5]. Interestingly, the prevalence of lifetime
depression in our sample appears to decline in the group aged
15–18 years. However as the ‘‘lifetime depression’’ label
considers past and current depressive episodes, this diminu-
tion is due to the cross-sectional design of this study.
Anxiety disorders were reported in 62.2 % of the sample.
These results are particularly significant considering that
diagnosis rates for anxiety disorders in non-syndromic
children, which vary widely between different studies, range
from a minimum figure of 2.6 % to a maximum of 41.2 %
[29]. In our study, the rates tended to increase with age,
affecting up to two-thirds of the adolescents in the age group
15–18 years. As stated previously, specific phobia is the
most common anxiety disorder at all ages in our study. These
findings were consistent with previous studies [1, 3]. Inter-
estingly, OCD occurred rather infrequently compared to the
results found in other studies on VCFS [10]. General anxiety
disorder and separation anxiety affected, respectively, 15
and 8 % of the sample and seemed to decline with age.
The type of anxiety disorders expressed at the earlier ages
reflects the practical and social consequences of the
syndrome. Indeed, SA and GAD can be considered, at least
initially, as reactions to the feelings of inadequacy and
physical vulnerability inherent to VCFS. As children age, the
rates of anxiety diseases increase as well as their severity,
resulting in a high prevalence of specifically described psy-
chopathologies, such as specific phobia and social phobia.
A recent study from Essex and collaborators focused on
early behavioral inhibition as a risk factor for the devel-
opment of chronic high school age inhibition [30], adding
more evidence to the association established between
childhood inhibition and later social anxiety disorders.
Since severe childhood inhibition is a characteristic often
displayed by VCFS children, the pathway leading to an
increased rate of adolescent anxiety disorders may not
differ from that of the general population. Further research
on this hypothesis may contribute to a better understanding
of the pathogenesis of anxiety disorders in VCFS popula-
tion as well as in the general population.
In our sample, low Vineland total scores were strongly
associated with higher CDI or R-CMAS total scores, lower
IQ and older age. These results show that the loss of
everyday adaptive skills and social functioning, as descri-
bed by parents, can be associated with an increase in the
severity of the depressive and anxiety symptoms reported
by the patients. Comparably, the association between
childhood depression and both low activities in daily life
and poor social adaptation has also been demonstrated in
children not affected by known genetic syndromes [19].
Additionally, this study points out age as a powerful
predictor of poor performance on the Vineland scale. The
decline of cognitive functioning throughout growth, espe-
cially verbal IQ, is a well-established correlate of the
syndrome [5, 16], recently linked to brain structural
changes [31, 32].
The results of our study suggest an association between
age-correlated cognitive loss, increased anxious–depres-
sive symptoms and age-correlated loss of daily and social
skills. Further studies could investigate brain structural
changes as possible common pathways of emotional, cog-
nitive and adaptive disruption occurring with age.
Limits
Our study had some limitations. First of all, the difficulty of
this research field in recruiting a large sample gave a
limited power to our statistical analyses. Particularly, the
differences in psychopathology rates between the age
groups were not statistically significant. For the same
reason, age had to be considered as a discontinuous rather
than a continuous variable. Another limitation of the
present article is the absence of a normative group.
Therefore, we had to rely on independent studies in order
to perform comparisons with the general population [33].
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Clinical implications
Both our clinical experience and current literature reveal
that caregivers as well as clinicians do not give adequate
attention to depression and anxiety disorders among syn-
dromic populations, especially among those characterized
by mental retardation [34]. Several reasons could account
for this lack of attention. Firstly, even if it is partially
explained by hypotonia, individuals with VCFS have a
limited ability to express their feelings through facial
expression and body posture. Secondly, social withdrawal,
one of the most typical features of the syndrome [35, 36],
highly affects their ability to communicate emotions, to the
extent that the children are often isolated and their feelings
neglected. Moreover, clinicians often accept sadness and
fear as a natural consequence of the severity of VCFS
rather than treatable comorbidity. The underestimation of
these difficulties may result in late interventions.
As discussed previously, the concurrent social and
academic issues that genetically vulnerable syndromic
preadolescents face appear to lead to increased depression
and anxiety disorders. In this critical period of life, indi-
viduals with VCFS and older individuals should be con-
sidered at higher risk and should receive special clinical
attention, as underestimating their anxious and depressive
symptoms could lead to a greater impairment in their social
and daily functioning.
Moreover, as already reported, anxious and depressive
symptoms are associated with psychotic symptoms [17, 37]
and with an increased risk for the emergence of psychotic
disorders in adulthood [16]. Regular screening and prompt
treatment of anxiety or depression are therefore likely to
decrease the rate of psychotic symptoms and subsequent
development of schizophrenia.
In addition, given their impact on adaptive skills and
future autonomy, depression and anxiety disorders should
be seriously considered when dealing with a child or an
adolescent with VCFS. As there is no evidence to suggest
that patients with VCFS respond differently to usual
treatments, compared to children and adolescents without
this syndrome, as soon as a diagnosis of depression or
anxiety is made, vigorous pharmacological and psycho-
therapeutic treatment should be considered.
Besides all the clinical considerations, the strong asso-
ciation between anxiety and depressive symptoms and
adaptive skills suggest that on the long run a suitable
treatment can improve social competencies and provide a
higher degree of autonomy in adulthood.
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